Chad Deisenroth

Dr. Chad Deisenroth

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
ABAngela R. Buckalew
Angela R. Buckalew
JWJun Wang
Jun Wang
AMAshley S. Murr
Ashley S. Murr
CDChad Deisenroth
Chad Deisenroth
WSWendy M. Stewart
Wendy M. Stewart
SLSusan C. Laws
Susan C. Laws

23 September 2016 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
BFBriana Foley
Briana Foley
DDDaniel Doheny
Daniel Doheny
MBMichael B. Black
Michael B. Black
SPSalil N. Pendse
Salil N. Pendse
BWBarbara A. Wetmore
Barbara A. Wetmore
CDChad Deisenroth
Chad Deisenroth
The developmental origins of obesity hypothesis posits a multifaceted contribution of factors to the fetal origins of obesity and metabolic disease. Adipocyte hyperplasia in gestation and early childhood may result in predisposition for obesity later in life. Rodent in vitro and in vivo studies indicate that some chemicals may directly affect adipose progenitor cell differentiation, but the human relevance of these findings is unclear. The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARG) is the master regulator of adipogenesis. Human adipose-derived stem cells (hASC) isolated from adipose tissue express endogenous isoforms of PPARG and represent a biologically relevant cell-type for evaluating activity of PPARG ligands. Here, a multi-endpoint approach based on a phenotypic adipogenesis assay was applied to screen a set of 60 chemical compounds identified in ToxCast Phase I as PPARG active (49) or inactive (11). Chemicals showing activity in the adipogenesis screen were further evaluated in a series of 4 orthogonal assays representing 7 different key events in PPARG-dependent adipogenesis, including gene transcription, protein expression, and adipokine secretion. An siRNA screen was also used to evaluate PPARG-dependence of the adipogenesis phenotype. A universal concentration-response design enabled inter-assay comparability and implementation of a weight-of-evidence approach for bioactivity classification. Collectively, a total of 14/49 (29%) prioritized chemicals were identified with moderate-to-strong activity for human adipogenesis. These results provide the first integrated screening approach of prioritized ToxCast chemicals in a human stem cell model of adipogenesis and provide insight into the capacity of PPARG-activating chemicals to modulate early life programming of adipose tissue.

1 October 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
NKNicole Kleinstreuer
Nicole Kleinstreuer
PBP. Browne
P. Browne
XCX. Chang
X. Chang
RJRichard Judson
Richard Judson
WCW. Casey
W. Casey
RTR.S. Thomas
R.S. Thomas

1 October 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
PBP. Browne
P. Browne
NKN.C. Kleinstreuer
N.C. Kleinstreuer
PCP. Ceger
P. Ceger
CDChad Deisenroth
Chad Deisenroth
NBN. Baker
N. Baker
WCW. Casey
W. Casey

6 December 2019 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
CDChad Deisenroth
Chad Deisenroth
VSValerie Y Soldatow
Valerie Y Soldatow
JFJermaine Ford
Jermaine Ford
WSWendy Stewart
Wendy Stewart
CBCassandra Brinkman
Cassandra Brinkman
RTRussell S Thomas
Russell S Thomas
Thyroid hormones (TH) are essential for regulating a number of diverse physiological processes required for normal growth, development, and metabolism. The US EPA Endocrine Disruptor Screening Program (EDSP) has identified several molecular thyroid targets relevant to hormone synthesis dynamics that have been adapted to high-throughput screening (HTS) assays to rapidly evaluate the ToxCast/Tox21 chemical inventories for potential thyroid disrupting chemicals (TDCs). The uncertainty surrounding the specificity of active chemicals identified in these screens and the relevance to phenotypic effects on in vivo human TH synthesis are notable data gaps for hazard identification of TDCs. The objective of this study was to develop a medium-throughput organotypic screening assay comprised of reconstructed human thyroid microtissues to quantitatively evaluate the disruptive effects of chemicals on TH production and secretion. Primary human thyroid cells procured from qualified euthyroid donors were analyzed for retention of NK2 homeobox 1 (NKX2-1), Keratin 7 (KRT7), and Thyroglobulin (TG) protein expression by high-content image analysis to verify enrichment of follicular epithelial cells. A direct comparison of 2-dimensional (2D) and 3-dimensional (3D) 96-well culture formats was employed to characterize the morphology, differential gene expression, TG production, and TH synthesis over the course of 20 days. The results indicate that modeling human thyroid cells in the 3D format was sufficient to restore TH synthesis not observed in the 2D culture format. Inhibition of TH synthesis in an optimized 3D culture format was demonstrated with reference chemicals for key molecular targets within the thyroid gland. Implementation of the assay may prove useful for interpreting phenotypic effects of candidate TDCs identified by HTS efforts currently underway in the EDSP.

1 October 2016 in Toxicology in Vitro
Verified
Journal Article
Closed access
VSValerie Soldatow
Valerie Soldatow
RPRichard C. Peffer
Richard C. Peffer
OTO. Joseph Trask
O. Joseph Trask
DCDavid E. Cowie
David E. Cowie
MAMelvin E. Andersen
Melvin E. Andersen
CDChad Deisenroth
Chad Deisenroth